Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03381716
Other study ID # SYNH-20171207
Secondary ID
Status Completed
Phase N/A
First received December 11, 2017
Last updated December 18, 2017
Start date June 19, 2002
Est. completion date May 29, 2016

Study information

Verified date December 2017
Source Shenyang Northern Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study evaluated the prevalence, presentation, management, and prognosis of coronary heart disease differ according to sex.


Description:

The study included 884 patients enrolled in our institute between June 2002 and May 2016. Considering psychosocial factors, treatments, and the outcomes in men versus those in women with acute aortic dissection, explored the association of sex with psychosocial characteristics and mortality risk. Of 884 patients, 211 (23.9%) were women. The median duration of follow-up was 2.9 years (25th -75th percentiles: 1-4 years ).


Recruitment information / eligibility

Status Completed
Enrollment 884
Est. completion date May 29, 2016
Est. primary completion date May 29, 2016
Accepts healthy volunteers No
Gender All
Age group 21 Years to 89 Years
Eligibility Inclusion Criteria:

- acute aortic dissection

Exclusion Criteria:

- Chronic aortic dissection

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
drug
Application bracket
Procedure:
Surgery
Surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shenyang Northern Hospital

References & Publications (1)

Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2017 Jun 30. doi: 10.1093/eurheartj/ehx319. [Epub ahead of print] — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The outcome measure describes aortic disease-related death,aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications. The study's primary endpoint during the follow up was the composite of aortic disease-related death, aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications during follow-up. 2.9years
See also
  Status Clinical Trial Phase
Completed NCT02732340 - Triple-branch Stent Graft Placement for the Treatment of Acute DeBakey I Aortic Dissection N/A
Recruiting NCT05484830 - Coagulation in Acute Aortic Dissection N/A
Recruiting NCT04122573 - Prospective Multicenter Study for Early Evaluation of Acute Chest Pain
Recruiting NCT02622750 - Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection Early Phase 1
Recruiting NCT05174767 - PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection N/A
Active, not recruiting NCT03414866 - Thoraflex Hybrid Post-Market Study
Not yet recruiting NCT05874700 - A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection N/A
Completed NCT05409677 - Perioperative Eosinophils Their Recovery in Type A Acute Aortic Dissection Prognosis
Recruiting NCT05206032 - Blood Biomarker Discovery by Raman Spectroscopy in Acute Aortic Dissection
Recruiting NCT06353607 - Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
Active, not recruiting NCT01894334 - Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection N/A